These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 31164163)
21. Overexpression of miR-331 Indicates Poor Prognosis and Promotes Progression of Breast Cancer. Jiang F; Zhang L; Liu Y; Zhou Y; Wang H Oncol Res Treat; 2020; 43(9):441-448. PubMed ID: 32818938 [TBL] [Abstract][Full Text] [Related]
22. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p. Yan K; Tian J; Shi W; Xia H; Zhu Y Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446 [TBL] [Abstract][Full Text] [Related]
23. Clinical significance and functions of miR-203a-3p/AVL9 axis in human non-small-cell lung cancer. Liang J; Sun T; Wang G; Zhang H Per Med; 2020 Jul; 17(4):271-282. PubMed ID: 32678693 [No Abstract] [Full Text] [Related]
24. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer. Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864 [TBL] [Abstract][Full Text] [Related]
25. Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis. Bai X; Wang Q; Rui X; Li X; Wang X Technol Cancer Res Treat; 2021; 20():1533033820985858. PubMed ID: 33416035 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer. Zhang J; Kong X; Shi Q; Zhao B Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982 [TBL] [Abstract][Full Text] [Related]
27. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer. Lu YJ; Liu RY; Hu K; Wang Y Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4. Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136 [TBL] [Abstract][Full Text] [Related]
29. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion. Zhou Z; Ma J Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-937 is overexpressed and predicts poor prognosis in patients with colon cancer. Liu H; Ma L; Wang L; Yang Y Diagn Pathol; 2019 Dec; 14(1):136. PubMed ID: 31856857 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-449a Is Downregulated in Cervical Cancer and Inhibits Proliferation, Migration, and Invasion. Wang L; Zhao Y; Xiong W; Ye W; Zhao W; Hua Y Oncol Res Treat; 2019; 42(11):564-571. PubMed ID: 31578014 [TBL] [Abstract][Full Text] [Related]
32. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911 [TBL] [Abstract][Full Text] [Related]
33. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells. Jin W; Han H; Liu D Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943 [TBL] [Abstract][Full Text] [Related]
34. MiR-19b-3p promotes tumor progression of non-small cell lung cancer via downregulating HOXA9 and predicts poor prognosis in patients. Li ZL; Li D; Yin GQ Histol Histopathol; 2022 Aug; 37(8):779-789. PubMed ID: 35274735 [TBL] [Abstract][Full Text] [Related]
35. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells. Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799 [TBL] [Abstract][Full Text] [Related]
36. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233 [TBL] [Abstract][Full Text] [Related]
38. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3. Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897 [TBL] [Abstract][Full Text] [Related]
39. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma. Liu S; Lin Z; Zheng Z; Rao W; Lin Y; Chen H; Xie Q; Chen Y; Hu Z Cancer Sci; 2020 Oct; 111(10):3881-3892. PubMed ID: 32589328 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1. Li J; Feng Q; Wei X; Yu Y Tumour Biol; 2016 Nov; 37(11):15221-15228. PubMed ID: 27683057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]